ResMed (RMD) Tops Q4 EPS by 2c, Beats on Revenues
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $220.37 -1.82%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $0.77, $0.02 better than the analyst estimate of $0.75. Revenue for the quarter came in at $556.7 million versus the consensus estimate of $555.73 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- PENN Entertainment (PENN) Reiterated at Market Outperform by Citizens as Relocation Announced
- KeyBanc Downgrades Kite Realty Group (KRG) to Sector Weight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
